Endometrial Cancer Molecularly Targeted Therapy Consortium
Enrolling By Invitation
18 years - 99 years
Female
Phase
N/A
50 participants needed
1 Location
Brief description of study
The purpose of this study is to confirm that tumor alterations and biomarkers can direct biologic therapies and potentially enhance survival outcomes in women with Endometrial Cancer
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Endometrial cancer,biorepository,biobanking
-
Age: 18 years - 99 years
-
Gender: Female
Updated on
04 Aug 2024.
Study ID: 848694
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
